Echographic characteristics of pericardial diseases in children with cancers and hematological cancers


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Health of Russia, Moscow Pericardial effusion may accompany malignant disease or be its first obvious clinical manifestation. The clinical interpretation of the presence and amount of pericardial effusion remains a subject for further study. Objective. To determine the incidence of pericardial diseases and their possible prognostic value in children and adolescents with cancers and hematological cancers. Subjects and methods. A total of 312 patients with cancers and hematological cancers were observed during the active development of the disease. Examinations were additionally made in 114 children and adolescents who had been admitted to the intensive care unit (ICU), including 53 patients (Group 1) with a fatal outcome and 61 patients (Group 2) who had been transferred from ICU to general wards after relief of life-threatening conditions. During the remission period, 253 children were examined at the rehabilitation stage. The diagnosis of a pericardial condition was based on ultrasound. Results. Among the 312 patients outside the ICU with an actively ongoing cancer process, pericardial effusion was detected in 79 (25.3%); out of them, 35 (44.3% of all patients with effusion) were found to have minimal effusion. Fifteen of these 35 patients had effusion in the presence of a systemic infection. Moderate effusion was recorded in 15 patients (19% of all patients with exudative pericarditis). There were no neoplastic cells or infectious agents in the pericardial fluid. Twenty-nine (36.7%) patients had a large effusion with the separation of epi- and pericardial layers in systole and diastole with an echo-free space over the anterior surface of the heart; in 15 of them, it was concurrent with a plural effusion. Small and moderate effusions did not affect the condition of patients. Large, long-lasting, and polyserositis-associated effusions were correlated with an unfavorable outcome. The volume of effusion, which was equal to or greater than that of the left ventricle and often concurrent with polyserositis, is regarded as critical, threatened by cardiac tamponade, was observed only in the group of children with a fatal outcome. At the stages of rehabilitation, pericardial effusion was rarely detected; it was minimal and did not affect prognosis. Conclusion. Effusive pericarditis frequently accompanies cancers. Recurrent large-volume effusions that are concurrent with those into other cavities and life-threatening are unfavorable. They are rarely associated with infection and suggest the underlying disease has a critical course, as well as they can be regarded as paraneoplastic.

Full Text

Restricted Access

About the authors

V. M Delyagin

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Health of Russia

Email: delyagin-doktor@yandex.ru
Moscow

References

  1. Burazor I., Imazio M., Markel G., Adler Y. Malignant Pericardial Effusion. Cardiology. 2013; 124 (4): 224-32. doi: 10.1159/000348559
  2. Minasian L., Davis M., Ky B. Cardiovascular Effects of Cancer Therapy. In: Niederhuber J., Armitage J., Kastan M., Doroshov J., Tepper J. (Eds.) Abeloff’s Clinical Oncology, 6th Ed. 2020; р. 649-64.e4
  3. Feigenbaum H. Echocardiography. 2nd Ed., Lea & Febiger, Philadelphia, 1976; 512 p.
  4. Nanda N., Gramiac R. Clinical echocardiography. Saint-Louis, 1978; 451 p.
  5. Rumacke C., Levine D. (Eds.) Diagnostic ultrasound. 5th Ed. 2018.
  6. Herlong J. Pediatric echocardiography. In: Coley B. (Ed.) Caffey’s pediatric diagnostic imaging. 13th Ed. 2019; p. 611-2.
  7. Ryding A. Pericardial disease. In: Ryding A., Newton J. (Eds.) Essential Echocardiography. 2nd Ed. 2013; p. 180-91.
  8. Hoit B. Anatomy and Physiology of the Pericardium. Cardiol Clin. 2017; 35 (4): 481-90. doi: 10.1016/j.ccl.2017.07.002
  9. Kucera F. Pericardial disease. Atlas of Pediatric Echocardiography. 2021; p. 253-62.
  10. Hegde Sh. Pericardial Disease. In: Solomon Sc.,Wu Ju., Gillam L. (Eds.) Essential Echocardiography. Companion to Braunwald’s heart Disease. 2019; p. 347-53.
  11. Soman B., Vijayarghavan G. Pericardial involvement in neoplastic disease: prevalence, clinical picture, diagnosis and treatment. European Society of Cardiology. 2017; 15 (25). URL: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-15/Pericardial-involvement-in-neoplastic-disease-prevalence-clinical-picture-diagnosis-and-treatment
  12. Lutz A., Schelbert E., Lontos K. et al. Acute Myeloid Leukemia preseting as Effusive Constrictive Pericarditis. CASE (Phila). 2020; 4 (2): 97-102. doi: 10.1016/j.case.2019.09.002
  13. Fashoyin-Ale L., Brahmer J. Malignancy-Related Effusion. In: Niederhuber J., Armitage J., Kastan M., Doroshov J., Tepper J. (Eds.) Abeloff’s Clinical Oncology, 6th Ed. 2020; p. 869-873.e4

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies